Asensus Surgical Performance
The firm shows a Beta (market volatility) of 1.11, which signifies a somewhat significant risk relative to the market. Asensus Surgical returns are very sensitive to returns on the market. As the market goes up or down, Asensus Surgical is expected to follow. Asensus Surgical right now shows a risk of 0.0%. Please confirm Asensus Surgical coefficient of variation and the relationship between the jensen alpha and skewness , to decide if Asensus Surgical will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Asensus Surgical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Asensus Surgical is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 6.3 M | |
| Free Cash Flow | -64.2 M |
Asensus |
Asensus Surgical Relative Risk vs. Return Landscape
If you would invest (100.00) in Asensus Surgical on September 2, 2024 and sell it today you would earn a total of 100.00 from holding Asensus Surgical or generate -100.0% return on investment over 90 days. Asensus Surgical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Asensus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Asensus Surgical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Asensus Surgical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Asensus Surgical, and traders can use it to determine the average amount a Asensus Surgical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ASXC |
Based on monthly moving average Asensus Surgical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Asensus Surgical by adding Asensus Surgical to a well-diversified portfolio.
Asensus Surgical Fundamentals Growth
Asensus Stock prices reflect investors' perceptions of the future prospects and financial health of Asensus Surgical, and Asensus Surgical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Asensus Stock performance.
| Return On Equity | -3.34 | |||
| Return On Asset | -0.76 | |||
| Operating Margin | (8.08) % | |||
| Current Valuation | 107.57 M | |||
| Shares Outstanding | 272.84 M | |||
| Price To Book | 7.09 X | |||
| Price To Sales | 9.64 X | |||
| Revenue | 8.58 M | |||
| EBITDA | (74.4 M) | |||
| Cash And Equivalents | 94.2 M | |||
| Cash Per Share | 0.40 X | |||
| Total Debt | 5.68 M | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | (63.63 M) | |||
| Earnings Per Share | (0.31) X | |||
| Total Asset | 60.53 M | |||
| Retained Earnings | (939.37 M) | |||
About Asensus Surgical Performance
By analyzing Asensus Surgical's fundamental ratios, stakeholders can gain valuable insights into Asensus Surgical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Asensus Surgical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Asensus Surgical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery in the United States, Europe, and Asia. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina. Asensus Surgical operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 153 people.Things to note about Asensus Surgical performance evaluation
Checking the ongoing alerts about Asensus Surgical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Asensus Surgical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Asensus Surgical is not yet fully synchronised with the market data | |
| Asensus Surgical has some characteristics of a very speculative penny stock | |
| Asensus Surgical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.58 M. Net Loss for the year was (78.43 M) with loss before overhead, payroll, taxes, and interest of (3.79 M). | |
| Asensus Surgical currently holds about 94.2 M in cash with (63.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4. |
- Analyzing Asensus Surgical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Asensus Surgical's stock is overvalued or undervalued compared to its peers.
- Examining Asensus Surgical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Asensus Surgical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Asensus Surgical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Asensus Surgical's stock. These opinions can provide insight into Asensus Surgical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Asensus Stock
If you are still planning to invest in Asensus Surgical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Asensus Surgical's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |